A groundbreaking new treatment for multiple sclerosis is set to begin clinical trials in Greece by mid-2024, offering hope to patients worldwide. Led by Dr. Steven Petratos of Monash University, the treatment, Diaprotectome, has shown promising results in preclinical studies, potentially reversing neurological damage caused by the disease. This oral therapy, designed to work alongside existing medications, will focus on improving cognitive function, fatigue, and disability progression, with plans to recruit 400 participants across Greece. If successful, it could mark a major breakthrough in the fight against MS.
Tag: Multiple sclerosis
Working in the disability space as a physiotherapist for many years, helping those who suffer from MS and other neurological disorders live a better life, in 2019 Irene Georgakopoulos found herself diagnosed with MS. The hope of inspiring others to soldier on, regardless of the unknown, is what drives Irene to push forward and bravely tell her inspiring story.
Hundreds of worshippers claimed to have witnessed a real-life miracle in the recent recovery of…
'Eros - Charity from the Heart' held its 5th Annual Fundraising Night in Sydney, Australia…
A Harvard Greek professor of neurology is behind the largest international research study into multiple…